中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
The Chinese Journal of Clinical Pharmacology
2015年
15期
1543-1545
,共3页
灯盏细辛注射液%中药注射剂%限定日剂量%限定日浓度%药物利用指数%平均用药频度%说明书
燈盞細辛註射液%中藥註射劑%限定日劑量%限定日濃度%藥物利用指數%平均用藥頻度%說明書
등잔세신주사액%중약주사제%한정일제량%한정일농도%약물이용지수%평균용약빈도%설명서
Dengzhanxixin injections%traditional Chinese medicine injections%defined daily dose%defined daily concentration%drug utiliza-tion index
目的:探讨灯盏细辛注射液临床使用合理性与安全性再评价问题。方法采取分层随机法抽取某医院2013年1至12月份使用灯盏细辛注射液住院病历120份,通过药品说明书推荐及药物利用研究,探讨灯盏细辛注射剂临床使用合理性与安全性再评价研究模式。结果该医院2013年灯盏细辛注射液临床使用中医辨病(34.17%)、中医辨证(18.33%)、溶媒剂量(35.83%)及给药浓度(2.50%)合理性百分率普遍偏低,8,7,6项指标合理性总得分百分率平均值亦不高(53.96%,56.55%,49.31%),尤其超浓度使用情况严重(aDDCs=28.09, cDUI=2.93>1)。结论应加强灯盏细辛注射液临床监测工作。
目的:探討燈盞細辛註射液臨床使用閤理性與安全性再評價問題。方法採取分層隨機法抽取某醫院2013年1至12月份使用燈盞細辛註射液住院病歷120份,通過藥品說明書推薦及藥物利用研究,探討燈盞細辛註射劑臨床使用閤理性與安全性再評價研究模式。結果該醫院2013年燈盞細辛註射液臨床使用中醫辨病(34.17%)、中醫辨證(18.33%)、溶媒劑量(35.83%)及給藥濃度(2.50%)閤理性百分率普遍偏低,8,7,6項指標閤理性總得分百分率平均值亦不高(53.96%,56.55%,49.31%),尤其超濃度使用情況嚴重(aDDCs=28.09, cDUI=2.93>1)。結論應加彊燈盞細辛註射液臨床鑑測工作。
목적:탐토등잔세신주사액림상사용합이성여안전성재평개문제。방법채취분층수궤법추취모의원2013년1지12월빈사용등잔세신주사액주원병력120빈,통과약품설명서추천급약물이용연구,탐토등잔세신주사제림상사용합이성여안전성재평개연구모식。결과해의원2013년등잔세신주사액림상사용중의변병(34.17%)、중의변증(18.33%)、용매제량(35.83%)급급약농도(2.50%)합이성백분솔보편편저,8,7,6항지표합이성총득분백분솔평균치역불고(53.96%,56.55%,49.31%),우기초농도사용정황엄중(aDDCs=28.09, cDUI=2.93>1)。결론응가강등잔세신주사액림상감측공작。
Objective To explore the method of research on the rationality and safety of traditional Chinese medicine injections ( TCMIs) in clinical use, such as Dengzhanxixin injections.Methods In this study, 120 medical records from the certain hospital, which contained Dengzhanxixin injections prescription during 2013 , were selected randomly and evalua-ted by instructions recommendation and drug utilization research ( DUR) .Results There were poor rationality and safety, such as in disease and syndrome differentiation of traditional Chinese medicine (34.17%and 18.33%for rationality, respectively), the solvent volume (35.83%for rationality), the administration concentration (2.50% for rationality) of Dengzhanxixin injections.The six or seven or eight param-eters total scores were 53.96%, 56.55%, 49.31% for rationality, respectively and there was super-concentration administration ( average defined daily concentration 28.09 and drug utilization index 2.93 ).Conclusion In brief, it should strengthen to monitor Dengzhanxixin injections in clinical use.